title: Infliximab for the treatment of extensive plaque psoriasis--regulation, cost and reimbursement.
authors.forename: Mordi
authors.initials: M
authors.lastname: Rabinovich
authors.forename: Menahem
authors.initials: M
authors.lastname: Fainaru
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D020811:Biomedical Technology / Q000191:economics; D003879:Dermatologic Agents / Q000191:economics / Q000627:therapeutic use*; D004059:Diffusion of Innovation; D016527:Drug Costs; D006801:Humans; D000069285:Infliximab; D007557:Israel; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence*; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab